x |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE |
SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2002 |
¨ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE |
SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from
to
|
| Delaware |
33-0723123 | |
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
| 47421 Bayside Parkway Fremont,
California |
94538 | |
| (Address of principal executive offices) |
(Zip Code) |
| Page | ||||
| PART I FINANCIAL INFORMATION |
||||
| Item 1. |
3 | |||
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 | ||||
| Item 2. |
12 | |||
| Item 3. |
35 | |||
| Item 4. |
36 | |||
| PART II OTHER INFORMATION |
||||
| Item 1. |
37 | |||
| Item 2. |
38 | |||
| Item 3. |
38 | |||
| Item 4. |
38 | |||
| Item 5. |
38 | |||
| Item 6. |
38 | |||
| 39 | ||||
| September 30, 2002 |
December 31, 2001 |
|||||||
| ASSETS |
||||||||
| Current assets: |
||||||||
| Cash and cash equivalents |
$ |
26,220 |
|
$ |
8,656 |
| ||
| Restricted cash |
|
5,000 |
|
|
2,333 |
| ||
| Accounts receivable, net |
|
31,255 |
|
|
14,188 |
| ||
| Inventories |
|
21,247 |
|
|
6,827 |
| ||
| Prepaid expenses and other current assets |
|
2,244 |
|
|
1,074 |
| ||
| |
|
|
|
|
| |||
| Total current assets |
|
85,966 |
|
|
33,078 |
| ||
| Property and equipment, net |
|
2,995 |
|
|
2,341 |
| ||
| Intangible and other assets, net |
|
1,054 |
|
|
1,033 |
| ||
| |
|
|
|
|
| |||
| Total assets |
$ |
90,015 |
|
$ |
36,452 |
| ||
| |
|
|
|
|
| |||
| LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
| Current liabilities: |
||||||||
| Accounts payable |
$ |
27,528 |
|
$ |
12,245 |
| ||
| Accrued liabilities |
|
10,451 |
|
|
7,813 |
| ||
| Deferred revenue |
|
21,896 |
|
|
6,033 |
| ||
| Notes payable to stockholders |
|
|
|
|
168 |
| ||
| Notes payable |
|
13,980 |
|
|
2,237 |
| ||
| |
|
|
|
|
| |||
| Total current liabilities |
|
73,855 |
|
|
28,496 |
| ||
| Deferred revenue |
|
9,020 |
|
|
1,748 |
| ||
| Notes payable, net |
|
120 |
|
|
|
| ||
| |
|
|
|
|
| |||
| Total liabilities |
|
82,995 |
|
|
30,244 |
| ||
| Stockholders equity: |
||||||||
| Common stock, $0.0001 par value: |
||||||||
| 200,000,000 shares authorized; 60,427,279 and 59,759,518 shares issued and outstanding |
|
6 |
|
|
6 |
| ||
| Additional paid-in capital |
|
146,383 |
|
|
147,609 |
| ||
| Unearned stock-based compensation |
|
(738 |
) |
|
(1,969 |
) | ||
| Notes receivable from stockholders |
|
(1,001 |
) |
|
(3,453 |
) | ||
| Accumulated deficit |
|
(137,421 |
) |
|
(135,856 |
) | ||
| Accumulated other comprehensive loss |
|
(209 |
) |
|
(129 |
) | ||
| |
|
|
|
|
| |||
| Total stockholders equity |
|
7,020 |
|
|
6,208 |
| ||
| |
|
|
|
|
| |||
| Total liabilities and stockholders equity |
$ |
90,015 |
|
$ |
36,452 |
| ||
| |
|
|
|
|
| |||
| Three Months Ended |
Nine Months Ended |
|||||||||||||||
| September 30, 2002 |
September 30, 2001 |
September 30, 2002 |
September 30, 2001 |
|||||||||||||
| Net revenues: |
||||||||||||||||
| Product revenues |
$ |
41,329 |
|
$ |
14,319 |
|
$ |
95,571 |
|
$ |
43,870 |
| ||||
| License and royalty revenues |
|
4,400 |
|
|
3,829 |
|
|
12,927 |
|
|
7,838 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Total net revenues |
|
45,729 |
|
|
18,148 |
|
|
108,498 |
|
|
51,708 |
| ||||
| Cost of product revenues (excludes stock-based compensation of $6, $(16), $28, and $35) |
|
34,295 |
|
|
12,942 |
|
|
80,163 |
|
|
53,061 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Gross margin |
|
11,434 |
|
|
5,206 |
|
|
28,335 |
|
|
(1,353 |
) | ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Operating expenses: |
||||||||||||||||
| Research and development (excludes stock-based compensation of $152, $322, $554 and $1,028) |
|
1,306 |
|
|
1,215 |
|
|
3,784 |
|
|
4,421 |
| ||||
| Sales and marketing (excludes stock-based compensation of $99, $87, $131 and $232) |
|
4,564 |
|
|
4,167 |
|
|
12,008 |
|
|
16,151 |
| ||||
| General and administrative (excludes stock-based compensation of $170, $(459), $628 and $554) |
|
2,259 |
|
|
2,500 |
|
|
6,635 |
|
|
10,171 |
| ||||
| Goodwill impairment |
|
|
|
|
|
|
|
|
|
|
2,854 |
| ||||
| Restructuring charge |
|
|
|
|
|
|
|
|
|
|
2,086 |
| ||||
| Stock-based compensation |
|
427 |
|
|
(66 |
) |
|
1,341 |
|
|
1,849 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Total operating expenses |
|
8,556 |
|
|
7,816 |
|
|
23,768 |
|
|
37,532 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Income (loss) from operations |
|
2,878 |
|
|
(2,610 |
) |
|
4,567 |
|
|
(38,885 |
) | ||||
| Other income (expense): |
||||||||||||||||
| Interest and other expense |
|
(115 |
) |
|
(545 |
) |
|
(571 |
) |
|
(3,911 |
) | ||||
| Interest and other income |
|
123 |
|
|
144 |
|
|
319 |
|
|
868 |
| ||||
| Foreign exchange gain (loss) |
|
10 |
|
|
194 |
|
|
224 |
|
|
(198 |
) | ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Total other income (expense) |
|
18 |
|
|
(207 |
) |
|
(28 |
) |
|
(3,241 |
) | ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Income (loss) before income taxes |
|
2,896 |
|
|
(2,817 |
) |
|
4,539 |
|
|
(42,126 |
) | ||||
| Income taxes |
|
853 |
|
|
676 |
|
|
6,104 |
|
|
2,276 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Net income (loss) |
$ |
2,043 |
|
$ |
(3,493 |
) |
$ |
(1,565 |
) |
$ |
(44,402 |
) | ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Net income (loss) per common share: |
||||||||||||||||
| Basic |
$ |
0.03 |
|
$ |
(0.06 |
) |
$ |
(0.03 |
) |
$ |
(0.77 |
) | ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Diluted |
$ |
0.03 |
|
$ |
(0.06 |
) |
$ |
(0.03 |
) |
$ |
(0.77 |
) | ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Shares used in net income (loss) per common share calculation: |
||||||||||||||||
| Basic |
|
59,654 |
|
|
58,547 |
|
|
59,356 |
|
|
57,912 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Diluted |
|
68,517 |
|
|
58,547 |
|
|
59,356 |
|
|
57,912 |
| ||||
| | ||||||||||||||||